FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | -71.7% | 14,641 | -92.2% | 0.00% | -77.8% |
| Q3 2020 | $881,000 | -33.5% | 187,497 | -13.6% | 0.01% | -35.7% |
| Q2 2020 | $1,324,000 | +4992.3% | 216,991 | +1800.9% | 0.01% | – |
| Q1 2020 | $26,000 | -98.4% | 11,415 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $1,658,000 | +252.8% | 361,299 | +198.0% | 0.02% | +166.7% |
| Q3 2019 | $470,000 | +103.5% | 121,243 | +216.9% | 0.01% | +100.0% |
| Q2 2019 | $231,000 | -74.6% | 38,260 | -43.7% | 0.00% | -76.9% |
| Q1 2019 | $910,000 | +79.8% | 67,947 | +24.8% | 0.01% | +44.4% |
| Q4 2018 | $506,000 | -33.2% | 54,447 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $758,000 | +9.1% | 54,447 | +23.8% | 0.01% | 0.0% |
| Q2 2018 | $695,000 | +44.5% | 43,990 | +57.2% | 0.01% | +37.5% |
| Q1 2018 | $481,000 | -4.6% | 27,990 | +21.7% | 0.01% | -11.1% |
| Q4 2017 | $504,000 | – | 22,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |